Search
for
Sort by
Research 781–810 of 1000+
- Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice
- Overview of Urethral Reconstruction by Tissue Engineering: Current Strategies, Clinical Status and Future Direction
- The Genetic Architecture of Alopecia Areata
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- A recently characterized, underdiagnosed cause of female androgenetic alopecia and polycystic ovarian syndrome: non-classical 21 hydroxylase deficiency
- The Influence of Monosaccharide Composition on the Bioactivity of Medicinal Plant Polysaccharides
- Pathophysiology of Androgenetic Alopecia and Implications for Treatment: An Overview of Current Literature
- Microneedling for Androgenetic Alopecia: A Synergistic Strategy Enhancing Drug Delivery and Follicular Regeneration
- Exosomes derived stem cells as a modern therapeutic approach for skin rejuvenation and hair regrowth
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Subject Index
- Facial Appearance and Markers of Cardiometabolic Risk in Healthy Adult Men
- Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers
- Alopecia areata susceptibility variant identified by MHC risk haplotype sequencing reproduces symptomatic patched hair loss in mice
- 0085 Th1/Th2 balance, IFN-γ–MHC-I axis, and regulatory T cells define therapeutic response endotypes in alopecia areata
- Transplantation immunology: Solid organ and bone marrow
- Exploring the overlap between alopecia areata and major depressive disorder: Epidemiological and genetic perspectives
- Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege
- Alopecia Areata is associated with MICA and an extended HLA haplotype
- 51223 A novel human disease model of alopecia areata to evaluate benefit of the DHODH inhibitor farudodstat
- 90 Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse
- LB1777 A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- Acquired and inheritedhair disorders
- ISIDLB1777 - A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- BI02 (P97): Epidermal growth factor receptor inhibitor therapy induces a distinct inflammatory hair follicle response that includes a collapse of immune privilege
- 061 Selective inhibition of tyrosine kinase 2 prevents and restores interleukin-12-induced hair follicle immune privilege collapse: a novel approach to alopecia areata therapy?
- Bioinformatics analysis of EST segment from goat
- Stem cell activity shapes the pleiotropic effects of IFN-γ and TGF-β in autoimmune diseases, infections, and cancer, and drives autoimmune flares and remissions
- 700 Tyrosine kinase 2 inhibition rescues hair follicles from IL-12–mediated immune privilege collapse and reverses the induction of human alopecia areata in a humanized mouse model
- An in silico approach to the identification of potential proteomic and genomic diagnostic biomarkers for primary cicatricial alopecia